CONTROLLED-RELEASE LEVODOPA

被引：0
|
作者：
BLUMENTHAL, HJ
机构：
来源：
NEUROLOGY | 1993年 / 43卷 / 12期
关键词：
D O I：
10.1212/WNL.43.12.2728-b
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
引用
收藏
页码：2728 / 2729
页数：2
相关论文
共 50 条
  • [21] Night-time bioavailability of levodopa/carbidopa/entacapone is higher compared to controlled-release levodopa/carbidopa
    Kuoppamaki, M.
    Sauramo, A.
    Korpela, K.
    Vahteristo, M.
    Kailajarvi, M.
    Lehtinen, T.
    Ellmen, J.
    [J]. INTERNATIONAL JOURNAL OF CLINICAL PHARMACOLOGY AND THERAPEUTICS, 2010, 48 (11) : 756 - 760
  • [22] THERAPEUTIC EFFECT OF A LEVODOPA BENSERAZIDE CONTROLLED-RELEASE PREPARATION ON NOCTURNAL AKINESIA IN PARKINSONISM
    BAAS, H
    FISCHER, PA
    ROTH, HJ
    [J]. NEW TRENDS IN CLINICAL NEUROPHARMACOLOGY: CALCIUM ANATONISTS, ACUTE NEUROLOGY, HEADACHE AND MOVEMENT DISORDERS, 1988, 7 : 311 - 313
  • [23] Soluble and controlled-release preparations of levodopa: do we really need them?
    Giovanni Fabbrini
    Flavio Di Stasio
    Maria Bloise
    Alfredo Berardelli
    [J]. Journal of Neurology, 2010, 257 : 292 - 297
  • [24] Evaluation and optimization of preparative variables for controlled-release floating microspheres of levodopa/carbidopa
    Choudhary, H.
    Agrawal, A. K.
    Malviya, R.
    Yadav, S. K.
    Jaliwala, Y. A.
    Patil, U. K.
    [J]. PHARMAZIE, 2010, 65 (03): : 194 - 198
  • [25] Soluble and controlled-release preparations of levodopa: do we really need them?
    Fabbrini, Giovanni
    Di Stasio, Flavio
    Bloise, Maria
    Berardelli, Alfredo
    [J]. JOURNAL OF NEUROLOGY, 2010, 257 : S292 - S297
  • [26] CLINICAL-EXPERIENCE WITH CONTROLLED-RELEASE CARBIDOPA LEVODOPA IN PARKINSONS-DISEASE
    PAHWA, R
    BUSENBARK, K
    HUBER, SJ
    MICHALEK, D
    HUBBLE, JP
    KOLLER, WC
    [J]. NEUROLOGY, 1993, 43 (04) : 677 - 681
  • [27] Immediate release and controlled-release carbidopa/levodopa in PD: A 5-year randomized multicenter study
    Van Horn, G
    Schiess, MC
    [J]. NEUROLOGY, 2000, 55 (01) : 156 - 157
  • [28] UNFORESEEN BENEFICIAL-EFFECTS OF CONTROLLED-RELEASE LEVODOPA-CARBIDOPA (SINEMET CR)
    MAKELA, EH
    CUTLIP, WD
    [J]. JOURNAL OF NEUROPSYCHIATRY AND CLINICAL NEUROSCIENCES, 1992, 4 (02) : 234 - 235
  • [29] The therapy of Morbus Parkinson with controlled-release Levodopa/Carbidopa (NACOM RETARD/Sinemet CR)
    Müller, T
    Kungel, M
    Rink, P
    Modell, S
    [J]. JOURNAL OF NEUROLOGY, 2004, 251 : 172 - 173
  • [30] ADVERSE REACTIONS TO CONTROLLED-RELEASE LEVODOPA CARBIDOPA IN OLDER PERSONS - CASE-REPORTS
    JOSEPH, CL
    SIPLE, J
    MCWHORTER, K
    CAMICIOLI, R
    [J]. JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 1995, 43 (01) : 47 - 50
12345